[HTML][HTML] Activation mechanisms of monocytes/macrophages in adult-onset Still disease

H Tsuboi, S Segawa, M Yagishita, H Toko… - Frontiers in …, 2022 - frontiersin.org
Adult onset Still disease (AOSD) is a systemic inflammatory disorder characterized by skin
rash, spiking fever, arthritis, sore throat, lymphadenopathy, and hepatosplenomegaly …

[HTML][HTML] Global research trends on ventricular remodeling: a bibliometric analysis from 2012 to 2022

T Meng, P Wang, J Ding, R Du, J Gao, A Li, S Yu… - Current problems in …, 2022 - Elsevier
Ventricular remodeling is the progressive pathologic change of the original substance and
morphology of the ventricle caused by various injuries and has attracted increasing attention …

Remimazolam attenuates myocardial ischemia-reperfusion injury by inhibiting the nf-ĸb pathway of macrophage inflammation

H Xu, Y Chen, P Xie, T Lei, K Liu, X Liu, J Tang… - European Journal of …, 2024 - Elsevier
Background Inflammation is a major contributing factor in myocardial ischemia/reperfusion
(I/R) injury, and targeting macrophage inflammation is an effective strategy for myocardial I/R …

Macrophage heterogeneity and its impact on myocardial ischemia-reperfusion injury: an integrative review

S Xu, C Xu, J Xu, K Zhang, H Zhang - Journal of Inflammation …, 2023 - Taylor & Francis
The coronary reperfusion following acute myocardial infarction can paradoxically trigger
myocardial ischemia-reperfusion (IR) injury. This complex phenomenon involves the …

Progress of Research into the Interleukin-1 Family in Cardiovascular Disease

Z Wu, C Luo, B Zheng - Journal of Inflammation Research, 2022 - Taylor & Francis
Inflammatory factors, such as the IL-1 family, are generally acknowledged to be involved in
systemic diseases and IL-1α and IL-1β, in particular, have been linked to cardiovascular …

IL-38 suppresses macrophage M1 polarization to ameliorate synovial inflammation in the TMJ via GLUT-1 inhibition

P Luo, M Du, Q Sun, T Zhao, H He - International Immunopharmacology, 2023 - Elsevier
Abstract Objectives Interleukin (IL)-38 was discovered as an anti-inflammatory factor.
However, IL-38′ s role in M1 macrophage polarization in the temporomandibular joint …

The effect of macrophages and their exosomes in ischemic heart disease

M Wang, C Li, Y Liu, Y Jin, Y Yu, X Tan… - Frontiers in …, 2024 - frontiersin.org
Ischemic heart disease (IHD) is a leading cause of disability and death worldwide, with
immune regulation playing a crucial role in its pathogenesis. Various immune cells are …

Emerging functions and therapeutic targets of IL‐38 in central nervous system diseases

Y Gao, L Cai, Y Wu, M Jiang, Y Zhang… - CNS Neuroscience …, 2024 - Wiley Online Library
Abstract Interleukin (IL)‐38 is a newly discovered cytokine of the IL‐1 family, which binds
various receptors (ie, IL‐36R, IL‐1 receptor accessory protein‐like 1, and IL‐1R1) in the …

Cardiomyocyte proliferation: Advances and insights in macrophage-targeted therapy for myocardial injury

T Wang, X Wang, W Ren, Z Sun, Y Zhang, N Wu… - Genes & …, 2024 - Elsevier
In the mammalian heart, cardiomyocytes undergo a transient window of proliferation that
leads to regenerative impairment, limiting cardiomyocyte proliferation and myocardial repair …

[HTML][HTML] 7-Hydroxyflavone alleviates myocardial Ischemia/Reperfusion Injury in rats by regulating inflammation

Q Zhang, Y Peng, J Liu, Y Yang, Z Hu, Y Zhou, J Ma… - Molecules, 2022 - mdpi.com
Inflammation is the primary pathological process of myocardial ischemia/reperfusion injury
(MI/RI). 7-Hydroxyflavone (HF), a natural flavonoid with a variety of bioactivities, plays a …